Literature DB >> 2419897

Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion.

K Berzins, H Perlmann, B Wåhlin, J Carlsson, M Wahlgren, R Udomsangpetch, A Björkman, M E Patarroyo, P Perlmann.   

Abstract

The Plasmodium falciparum-derived antigen of Mr 155,000 designated Pf 155, deposited in the membrane of infected erythrocytes, contains at least two blocks of tandemly repeated amino acid sequences. The peptide Glu-Glu-Asn-Val-Glu-His-Asp-Ala, which corresponds to a subunit of a C-terminally located repeat, was synthesized. Rabbits immunized with the octapeptide conjugated with either keyhole limpet hemocyanine or tetanus toxoid formed antibodies against the octapeptide. These antibodies reacted with Pf 155 as detected by immunoblotting or a modified immunofluorescence assay. Sera from humans exposed to P. falciparum also contained antibodies binding to the octapeptide in a dot-blot immunoassay. Their anti-octapeptide titers were correlated with their immunofluorescence titers in the assay detecting Pf 155 and other parasite antigens in the membrane of infected erythrocytes. Human octapeptide-reactive antibodies were isolated on an affinity column with the octapeptide conjugated to bovine serum albumin as ligand. These human antibodies reacted with Pf 155 in immunoblotting and strongly stained the surface of infected erythrocytes in the modified immunofluorescence assay. Approximately 20% of this immunofluorescence activity in a high-titered human serum could be recovered from the octapeptide column, indicating that a significant fraction of these anti-parasite antibodies react with epitopes associated with the octapeptide. Furthermore, the human octapeptide-reactive antibodies very efficiently inhibited merozoite reinvasion into erythrocytes in vitro. Similarly purified rabbit antibodies also significantly inhibited reinvasion. Our results suggest that the C-terminal segment of repeated peptides in Pf 155 is a major antigenic region of the molecule and may contain target sites for protective immunity in P. falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419897      PMCID: PMC323011          DOI: 10.1073/pnas.83.4.1065

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Isolate-specific S-antigen of Plasmodium falciparum contains a repeated sequence of eleven amino acids.

Authors:  R L Coppel; A F Cowman; K R Lingelbach; G V Brown; R B Saint; D J Kemp; R F Anders
Journal:  Nature       Date:  1983 Dec 22-1984 Jan 4       Impact factor: 49.962

2.  Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies.

Authors:  M R Hollingdale; E H Nardin; S Tharavanij; A L Schwartz; R S Nussenzweig
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

3.  Immune sera recognize on erythrocytes Plasmodium falciparum antigen composed of repeated amino acid sequences.

Authors:  R L Coppel; A F Cowman; R F Anders; A E Bianco; R B Saint; K R Lingelbach; D J Kemp; G V Brown
Journal:  Nature       Date:  1984 Aug 30-Sep 5       Impact factor: 49.962

4.  Induction with a synthetic peptide of antibodies to HLA class I C-terminal intracytoplasmic region.

Authors:  G Rougon; B Ceard; J Van Rietschoten; B Jordan; J Barbet
Journal:  Mol Immunol       Date:  1984-06       Impact factor: 4.407

5.  Human antisera detect a Plasmodium falciparum genomic clone encoding a nonapeptide repeat.

Authors:  M Koenen; A Scherf; O Mercereau; G Langsley; L Sibilli; P Dubois; L Pereira da Silva; B Müller-Hill
Journal:  Nature       Date:  1984 Sep 27-Oct 3       Impact factor: 49.962

6.  Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum.

Authors:  J B Dame; J L Williams; T F McCutchan; J L Weber; R A Wirtz; W T Hockmeyer; W L Maloy; J D Haynes; I Schneider; D Roberts
Journal:  Science       Date:  1984-08-10       Impact factor: 47.728

7.  DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope.

Authors:  V Enea; J Ellis; F Zavala; D E Arnot; A Asavanich; A Masuda; I Quakyi; R S Nussenzweig
Journal:  Science       Date:  1984-08-10       Impact factor: 47.728

8.  Surface proteins of Plasmodium falciparum merozoites binding to the erythrocyte receptor, glycophorin.

Authors:  M E Perkins
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

9.  Neutralization of the infectivity of sporozoites of Plasmodium knowlesi by antibodies to a synthetic peptide.

Authors:  J Gysin; J Barnwell; D H Schlesinger; V Nussenzweig; R S Nussenzweig
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

10.  Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum.

Authors:  H Perlmann; K Berzins; M Wahlgren; J Carlsson; A Björkman; M E Patarroyo; P Perlmann
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  26 in total

1.  Epitope mapping of B-cell determinants on the 15-kilodalton lipoprotein of Treponema pallidum (Tpp15) with synthetic peptides.

Authors:  R E Baughn; M Demecs; L H Taber; D M Musher
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Movement of a falciparum malaria protein through the erythrocyte cytoplasm to the erythrocyte membrane is associated with lysis of the erythrocyte and release of gametes.

Authors:  I A Quakyi; Y Matsumoto; R Carter; R Udomsangpetch; A Sjolander; K Berzins; P Perlmann; M Aikawa; L H Miller
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Antibodies to a histidine-rich protein (PfHRP1) disrupt spontaneously formed Plasmodium falciparum erythrocyte rosettes.

Authors:  J Carlson; G Holmquist; D W Taylor; P Perlmann; M Wahlgren
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Absence of antigenic diversity in Pf155, a major parasite antigen in membranes of erythrocytes infected with Plasmodium falciparum.

Authors:  H K Perlmann; K Berzins; B Wåhlin; R Udomsangpetch; W Ruangjirachuporn; M Wahlgren; P H Perlmann
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

5.  Plasmodium chabaudi antigen Pch105, Plasmodium falciparum antigen Pf155, and erythrocyte band 3 share cross-reactive epitopes.

Authors:  G Holmquist; R Udomsangpetch; K Berzins; H Wigzell; P Perlmann
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

6.  Genetic regulation of human anti-malarial antibodies in twins.

Authors:  K Sjöberg; J P Lepers; L Raharimalala; A Larsson; O Olerup; N T Marbiah; M Troye-Blomberg; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

7.  Seroreactivity with the Plasmodium falciparum blood stage antigen Pf332 in adults and children from malaria-endemic regions.

Authors:  J Iqbal; P Perlmann; B M Greenwood; K Berzins
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

8.  Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.

Authors:  Preeyaporn Monatrakul; Mathirut Mungthin; Arjen M Dondorp; Srivicha Krudsood; Rachanee Udomsangpetch; Polrat Wilairatana; Nicholas J White; Kesinee Chotivanich
Journal:  Malar J       Date:  2010-11-16       Impact factor: 2.979

9.  Characterization of a 96-kilodalton thermostable polypeptide antigen of Plasmodium falciparum related to protective immunity in the squirrel monkey.

Authors:  H Jouin; P Dubois; J Gysin; T Fandeur; O Mercereau-Puijalon; L P da Silva
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

10.  Isotypic analysis of Plasmodium falciparum-specific antibodies and their relation to protection in Madagascar.

Authors:  B Dubois; P Deloron; P Astagneau; C Chougnet; J P Lepers
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.